Related Experiment Video
Updated: Jul 18, 2026
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Acute otitis media unresponsive to treatment
1University of Colorado, Health Sciences Center, Denver, Colorado, USA.
Summary
Unresponsive acute otitis media occurs in 10% of children despite antibiotic treatment. This review discusses managing this persistent ear inflammation beyond 48 hours of therapy.
Area of Science:
- Pediatric infectious diseases
- Otolaryngology
- Pharmacology
Background:
- Acute otitis media (AOM) is a common childhood infection.
- Treatment failure occurs in approximately 10% of cases, leading to unresponsive AOM.
- Unresponsive AOM is defined by persistent inflammation beyond 48 hours of initial antibiotic therapy.
Purpose of the Study:
- To review the current management strategies for unresponsive acute otitis media in children.
- To provide guidance on therapeutic approaches for persistent AOM.
- To highlight key considerations in the treatment of antibiotic-resistant ear infections.
Main Methods:
- Literature review of studies on AOM management.
- Analysis of clinical guidelines for pediatric ear infections.
- Synthesis of evidence regarding second-line therapies and diagnostic approaches.
Main Results:
- Unresponsive AOM necessitates re-evaluation of diagnosis and treatment.
- Options include changing antibiotics, considering alternative pathogens, or addressing non-infectious causes.
- Close monitoring and follow-up are crucial for successful outcomes.
Conclusions:
- Effective management of unresponsive AOM requires a systematic approach.
- Tailoring treatment based on clinical presentation and potential resistance patterns is essential.
- Further research into optimal therapeutic regimens for refractory cases is warranted.
Related Concept Videos
01:26Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...